Table 5.
Treatments | Menoufia Governorate | ||||
---|---|---|---|---|---|
Damping-Off % | Disease Incidence % | % Efficacy | |||
Pre-Emergence | Post-Emergence | Survival | |||
Cu2ONPs (0.35) | 12.0 b ± 0.65 | 18.7 c ± 0.68 | 69.3 b ± 1.23 | 24.7 b ± 0.54 | 63.8 |
Cu2ONPs (0.30) | 9.3 c ± 0.56 | 10.3 b ± 0.54 | 80.4 a ± 1.41 | 21.9 c ± 0.46 | 67.9 |
Fungicide (Uniform 390 SE) |
7.3 c ± 0.51 | 11.3 b ± 0.57 | 81.4 a ± 1.46 | 18.0 d ± 0.44 | 73.6 |
Control | 14.5a ± 0.72 | 29.2 a ± 0.81 | 56.3 c ± 1.27 | 68.3 a ± 1.75 | 0.0 |
Giza Governorate | |||||
Cu2ONPs (0.35) | 9.7 b ± 0.58 | 12.7 c ± 0.59 | 77.6 c ± 1.34 | 21.3 b ± 0.58 | 70.17 |
Cu2ONPs (0.30) | 7.4 c ± 0.51 | 11.3 b ± 0.56 | 81.6 b ± 1.42 | 20.4 b ± 0.66 | 71.43 |
Fungicide (Uniform 390 SE) |
5.7 c ± 0.47 | 10.3 b ± 0.51 | 84.0 a ± 1.44 | 17.3 c ± 0.51 | 75.77 |
Control | 13.5 a ± 0.62 | 31.7 a ± 0.74 | 54.8 d ± 1.04 | 71.4 a ± 1.42 | 0.0 |
Statistical comparisons were made among treatments within a single column. * The different letters represent significant differences using Fisher’s LSD test at p ≤ 0.05. Each mean value came from three replicates.